Historical shareholding details of Strategic Advisers U.S. Total Stock holdings in Cytokinetics Inc (CYTK)

Monthly changes of Strategic Advisers U.S. Total Stock shareholding in Cytokinetics Inc over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Strategic Advisers U.S. Total Stock 156,834 0.13%
Dec 31, 2024 Strategic Advisers U.S. Total Stock 156,834 0.13%
Nov 30, 2024 Strategic Advisers U.S. Total Stock 163,834 0.14%
Oct 31, 2024 Strategic Advisers U.S. Total Stock 174,741 0.15%
Sep 30, 2024 Strategic Advisers U.S. Total Stock 176,741 0.15%
Jul 31, 2024 Strategic Advisers U.S. Total Stock 58,500 0.05%
Jun 30, 2024 Strategic Advisers Large Cap 58,500 0.05%
May 31, 2024 Strategic Advisers Large Cap 68,000 0.06%
Apr 30, 2024 Strategic Advisers Large Cap 62,800 0.05%
Mar 31, 2024 Strategic Advisers Large Cap 67,000 0.06%
Feb 29, 2024 Strategic Advisers Large Cap 69,000 0.07%
Jan 31, 2024 Strategic Advisers Large Cap 64,200 0.06%
Dec 31, 2023 Strategic Advisers Large Cap 69,000 0.07%
Oct 31, 2023 Strategic Advisers® Large Cap 54,000 0.06%
Sep 30, 2023 Strategic Advisers® Large Cap 54,000 0.06%
Jul 31, 2023 Strategic Advisers® Large Cap 54,000 0.06%
Jun 30, 2023 Strategic Advisers® Large Cap 60,000 0.06%
Apr 30, 2023 Strategic Advisers® Large Cap 60,000 0.06%

View all ownership details of Cytokinetics Inc